Home
About
Overview
Sharing Data
ORCID
Help
History (25)
The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.
Carcinoma 256, Walker
Arginase
Truncus Arteriosus, Persistent
Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.
Sclerostin antibody increases bone volume and enhances implant fixation in a rat model. J Bone Joint Surg Am. 2012 Sep 19; 94(18):1670-80.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Biomechanical Phenomena
Disease Models, Animal
Dose-Response Relationship, Drug
Drug Administration Schedule
Femur
Male
Osteogenesis
Prosthesis Implantation
Random Allocation
Rats
Rats, Sprague-Dawley
Reference Values
Risk Assessment
Tensile Strength
Titanium
Treatment Outcome
X-Ray Microtomography
authors with profiles
Kotaro Sena
Amarjit S Virdi
Dale R Sumner